A detailed history of Acorn Creek Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Acorn Creek Capital LLC holds 3,388 shares of NVS stock, worth $349,201. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,388
Previous 3,311 2.33%
Holding current value
$349,201
Previous $352 Million 10.55%
% of portfolio
0.21%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$106.13 - $120.89 $8,172 - $9,308
77 Added 2.33%
3,388 $390 Million
Q2 2024

Jul 18, 2024

BUY
$92.57 - $107.37 $28,233 - $32,747
305 Added 10.15%
3,311 $352 Million
Q1 2024

Apr 24, 2024

SELL
$95.27 - $108.47 $7,621 - $8,677
-80 Reduced 2.59%
3,006 $291 Million
Q4 2023

Feb 12, 2024

BUY
$92.27 - $101.54 $284,745 - $313,352
3,086 New
3,086 $312 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Acorn Creek Capital LLC Portfolio

Follow Acorn Creek Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acorn Creek Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acorn Creek Capital LLC with notifications on news.